title: Isolated recurrence of secondary CNS lymphoma: case report and literature review.
abstract: Isolated secondary central nervous system lymphoma (SCNSL) relapse is a rare disease. Consequently, standardized treatment regimens have yet to be developed. We present an interesting case of isolated SCNSL presenting with altered mental status and panhypopituitarism in a patient at low risk of developing the disease. We also review the related literature and discuss newer, more aggressive treatments for primary CNS lymphoma and SCNSL.
authors.affiliation: Department of Neurological Surgery, The George Washington University, Washington, District of Columbia, United States.
authors.forename: Peter
authors.initials: P
authors.lastname: DeRosa
authors.affiliation: School of Medical and Health Sciences, The George Washington University, Washington, District of Columbia, United States.
authors.forename: Justin M
authors.initials: JM
authors.lastname: Cappuzzo
authors.affiliation: Department of Neurological Surgery, The George Washington University, Washington, District of Columbia, United States.
authors.forename: Jonathan H
authors.initials: JH
authors.lastname: Sherman
keywords: aggressive treatment regimen; isolated; recurrence; relapse; secondary central nervous system lymphoma
references.citation: Semin Neurol. 2004 Dec;24(4):395-404
references.pmid: 15637651
references.citation: J Neurooncol. 2002 Jun;58(2):175-8
references.pmid: 12164690
references.citation: Ann Oncol. 2012 Oct;23(10):2670-2675
references.pmid: 22473593
references.citation: Leuk Lymphoma. 2008;49 Suppl 1:52-8
references.pmid: 18821433
references.citation: J Neurooncol. 2013 May;113(1):27-32
references.pmid: 23456654
references.citation: Ophthalmic Plast Reconstr Surg. 2010 Jul-Aug;26(4):291-3
references.pmid: 20523257
references.citation: Ann Hematol. 2011 May;90(5):539-46
references.pmid: 20960190
references.citation: Blood. 1998 Feb 15;91(4):1178-84
references.pmid: 9454747
references.citation: Am J Clin Oncol. 1991 Dec;14(6):478-82
references.pmid: 1720278
references.citation: J Neurosurg. 1999 Aug;91(2):221-30
references.pmid: 10433310
references.citation: Leuk Lymphoma. 2000 Jul;38(3-4):335-43
references.pmid: 10830740
references.citation: Cancer. 1982 Feb 1;49(3):586-95
references.pmid: 7059915
references.citation: Virchows Arch A Pathol Anat Histol. 1976 Jul 21;370(4):345-62
references.pmid: 826017
references.citation: Leuk Lymphoma. 1999 Feb;32(5-6):571-6
references.pmid: 10048430
references.citation: Int J Clin Oncol. 2012 Aug;17(4):336-40
references.pmid: 21904968
references.citation: Blood. 2013 Oct 3;122(14):2318-30
references.pmid: 23963042
references.citation: J Neurooncol. 2010 May;97(3):389-92
references.pmid: 19841864
references.citation: Clin Med Insights Oncol. 2012;6:219-31
references.pmid: 22654527
references.citation: J Clin Oncol. 1991 Sep;9(9):1580-90
references.pmid: 1875220
references.citation: J Clin Oncol. 2009 Jul 20;27(21):3503-9
references.pmid: 19451444
references.citation: AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):984-92
references.pmid: 20616176
references.citation: Br J Haematol. 2012 Sep;158(5):600-7
references.pmid: 22734565
references.citation: Neurology. 2002 May 28;58(10):1513-20
references.pmid: 12034789
references.citation: Ann Oncol. 2004 Jan;15(1):129-33
references.pmid: 14679132
references.citation: Acta Haematol. 2012;127(2):93-5
references.pmid: 22156510
references.citation: Int J Hematol. 2006 Aug;84(2):128-35
references.pmid: 16926134
references.citation: Ger Med Sci. 2011;9:Doc11
references.pmid: 21698087
references.citation: Ann Oncol. 2007 Jan;18(1):149-157
references.pmid: 17018708
references.citation: Blood. 2009 Apr 23;113(17):3896-902
references.pmid: 19144985
references.citation: Br J Cancer. 2010 Feb 16;102(4):673-7
references.pmid: 20125159
references.citation: Curr Treat Options Neurol. 2014 Jan;16(1):277
references.pmid: 24343307
references.citation: Aust N Z J Med. 1985 Feb;15(1):16-21
references.pmid: 3859259
references.citation: Front Radiat Ther Oncol. 1999;33:349-53
references.pmid: 10549506
references.citation: Neurosurg Focus. 2006 Nov 15;21(5):E4
references.pmid: 17134120
references.citation: Ann Oncol. 2005 Mar;16(3):450-4
references.pmid: 15642707
references.citation: Blood. 2005 Jan 15;105(2):496-502
references.pmid: 15358629
references.citation: Neurology. 1996 Feb;46(2):435-9
references.pmid: 8614508
references.citation: Lancet Oncol. 2011 Dec;12(13):1258-66
references.pmid: 21933751
references.citation: Neurology. 2012 Aug 28;79(9):890-6
references.pmid: 22895585
references.citation: Expert Rev Anticancer Ther. 2013 Nov;13(11):1327-37
references.pmid: 24152125
references.citation: Neurology. 2002 Feb 12;58(3):390-6
references.pmid: 11839837
references.citation: Ann Oncol. 2009 Feb;20(2):319-25
references.pmid: 18953065
references.citation: Neuro Oncol. 2012 Dec;14(12):1481-4
references.pmid: 22984018
references.citation: Ann Oncol. 2011 Sep;22(9):2080-2085
references.pmid: 21303800